carteolol has been researched along with Cardiomegaly in 3 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Cardiomegaly: Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The beta-blocking potency, estimated from the area under the dose-response curve (beta-blocking action) of carteolol, was also 300 times greater than that of propranolol and correlated well with the extent of the structural changes in the heart." | 5.27 | Dose-related inhibitory effects of the beta-adrenoceptor blocking drugs carteolol and propranolol on cardiac hypertrophy in spontaneously hypertensive rats. ( Igawa, T; Ikezono, K; Kimura, Y; Watanabe, K, 1984) |
| " In this study, we investigated the effect of chronic administration of carteolol (4 mg/kg/day p." | 1.28 | Effect of long-term treatment with beta-blocker on cardiac hypertrophy in SHR. ( Ieki, K; Kojima, M; Komuro, I; Seko, Y; Sugiyama, T; Takaku, F; Tsuchimochi, H; Yamaoki, K; Yazaki, Y; Yoshizumi, M, 1989) |
| " The beta-blocking potency, estimated from the area under the dose-response curve (beta-blocking action) of carteolol, was also 300 times greater than that of propranolol and correlated well with the extent of the structural changes in the heart." | 1.27 | Dose-related inhibitory effects of the beta-adrenoceptor blocking drugs carteolol and propranolol on cardiac hypertrophy in spontaneously hypertensive rats. ( Igawa, T; Ikezono, K; Kimura, Y; Watanabe, K, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Igawa, T | 1 |
| Ikezono, K | 1 |
| Watanabe, K | 1 |
| Kimura, Y | 1 |
| Rosales, OR | 1 |
| Sander, GE | 1 |
| Roffidal, L | 1 |
| Given, MB | 1 |
| Giles, TD | 1 |
| Ieki, K | 1 |
| Yazaki, Y | 1 |
| Yamaoki, K | 1 |
| Tsuchimochi, H | 1 |
| Yoshizumi, M | 1 |
| Komuro, I | 1 |
| Sugiyama, T | 1 |
| Seko, Y | 1 |
| Takaku, F | 1 |
| Kojima, M | 1 |
3 other studies available for carteolol and Cardiomegaly
| Article | Year |
|---|---|
Dose-related inhibitory effects of the beta-adrenoceptor blocking drugs carteolol and propranolol on cardiac hypertrophy in spontaneously hypertensive rats.
Topics: Animals; Body Weight; Cardiomegaly; Carteolol; Dose-Response Relationship, Drug; Drinking; Heart Rat | 1984 |
Carteolol, an antihypertensive beta-blocker with intrinsic sympathomimetic activity, reduces ECG evidence of left ventricular hypertrophy.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Carteolol; Electrocardiography; Humans; | 1989 |
Effect of long-term treatment with beta-blocker on cardiac hypertrophy in SHR.
Topics: Adrenergic beta-Antagonists; Animals; Cardiomegaly; Carteolol; Hydroxyproline; Male; Myosins; Propra | 1989 |